Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series

BACKGROUND: Children with rheumatic diseases (cRD) receiving immunosuppressive medications (IM) are at a higher risk for acquiring potentially lethal pathogens, including Histoplasma capsulatum (histoplasmosis), a fungal infection that can lead to prolonged hospitalization, organ damage, and death....

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Rachel A., Barbar-Smiley, Fatima, Yildirim-Toruner, Cagri, Ardura, Monica I., Ardoin, Stacy P., Akoghlanian, Shoghik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185916/
https://www.ncbi.nlm.nih.gov/pubmed/34098976
http://dx.doi.org/10.1186/s12969-021-00581-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185916/
https://www.ncbi.nlm.nih.gov/pubmed/34098976
http://dx.doi.org/10.1186/s12969-021-00581-7

Ejemplares similares